Copyright
©The Author(s) 2024.
World J Clin Cases. Jun 26, 2024; 12(18): 3468-3475
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3468
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3468
Table 4 Subgroup analysis of serum uric acid level changes
| Subgroups | Dapagliflozin group | Placebo group |
| Age | -1.3 ± 0.7 | -0.2 ± 0.6 |
| Sex | -1.2 ± 0.8 | -0.1 ± 0.7 |
| Diabetes status | -1.1 ± 0.8 | -0.2 ± 0.7 |
| Baseline serum uric acid level | -1.2 ± 0.8 | -0.1 ± 0.7 |
| Baseline eGFR | -1.1 ± 0.8 | -0.1 ± 0.7 |
- Citation: Lin MJ, Zou SB, Zhu BX. Effect of dapagliflozin on uric acid in patients with chronic heart failure and hyperuricemia. World J Clin Cases 2024; 12(18): 3468-3475
- URL: https://www.wjgnet.com/2307-8960/full/v12/i18/3468.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i18.3468